In this animal model, MS was induced by administering myelin oligodendrocyte glycoprotein (MOG) or guinea pig spinal cord homogenate (GPSCH), with MOG accounting for the majority of incidences. The gene discussed is MOG; the disease is myeloid sarcoma.